Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results CC transcript Filed Chapter 11 Director departure
|
BAXANO SURGICAL, INC. (BAXS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/10/2015 |
SC 13G/A
| ADVANCED TECHNOLOGY VENTURES VII LP reports a 0% stake in Baxano Surgical, Inc. |
11/14/2014 |
8-K
| Quarterly results |
11/12/2014 |
8-K
| Resignation/termination of a director |
10/31/2014 |
8-K
| Resignation/termination of a director |
09/24/2014 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
08/14/2014 |
10-Q
| Quarterly Report for the period ended June 30, 2014 |
08/05/2014 |
8-K
| Quarterly results |
07/24/2014 |
SC 13G/A
| DELPHI VENTURES VI LP reports a 2.3% stake in Baxano Surgical, Inc. |
07/14/2014 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
06/06/2014 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
05/13/2014 |
10-Q
| Quarterly Report for the period ended March 31, 2014 |
05/08/2014 |
8-K
| Quarterly results |
04/17/2014 |
8-K
| Submission of Matters to a Vote of Security Holders |
03/24/2014 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/14/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
03/14/2014 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs:
|
"Form of Securities Purchase Agreement, by and among Baxano Surgical, Inc. and the purchasers named therein",
"Subordination Agreement, by and among Baxano Surgical, Inc., Hercules Technology Growth Capital, Inc., and the creditors named therein",
"General Release and Severance Agreement, between Baxano Surgical, Inc. and Rick Feiler",
"Baxano Surgical, Inc. Announces $10 Million Private Placement of Convertible Debentures",
"Baxano Surgical, Inc. Announces Changes to Executive Management Team RALEIGH, NC — —March 14, 2014— Baxano Surgical, Inc. , a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region, today announced changes to its executive management team. · Tim Shannon has been appointed Chief Financial Officer effective March 14, 2014 · Matt Pickens has been appointed Vice President of Marketing and Reimbursement effective March 14, 2014 · Rick Feiler, Vice President of Marketing & Professional Education, has resigned effective April 15, 2014 and will assist in the transition process over the next month Tim Shannon joined Baxano Surgical in 2013 and has served as Inter..." |
|
03/11/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
03/11/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
03/07/2014 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
02/14/2014 |
SC 13G
| Presidio Partners 2007, L.P. reports a 7.5% stake in Baxano Surgical, Inc. |
02/11/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/06/2014 |
SC 13G/A
| DELPHI VENTURES VI LP reports a 5.3% stake in Baxano Surgical, Inc. |
01/17/2014 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
01/08/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
12/03/2013 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)] |
12/03/2013 |
8-K
| Form 8-K - Current report |
11/12/2013 |
10-Q
| Quarterly Report for the period ended September 30, 2013 |
09/23/2013 |
SC 13G/A
| CUTLASS CAPITAL LP reports a 4.5% stake in Baxano Surgical, Inc. |
08/14/2013 |
10-Q
| Quarterly Report for the period ended June 30, 2013 |
08/12/2013 |
8-K
| Quarterly results |
07/05/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
07/05/2013 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
06/26/2013 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933 |
06/26/2013 |
8-K/A
| Financial Statements and Exhibits
Docs:
|
"Consent of PricewaterhouseCoopers LLP",
"Audited Financial Statements of Baxano, Inc. as of and for the years ended December 31, 2012 and 2011",
"Unaudited Financial Statements of Baxano, Inc. as of March 31, 2013 and December 31, 2012 and for the three months ended March 31, 2013 and 2012",
"Unaudited Pro Forma Condensed Combined Financial Information of Baxano Surgical, Inc" |
|
|
|
|